Control of Chagas disease

World Health Organization - Technical Report Series

Volumn , Issue 905, 2002, Pages 1-99

  Coura, J R ^a   Dias, J C P ^a   Frasch, A C C ^a   Guhl, F ^a   Lazzari, J O ^a   Lorca, M ^a   Monroy Escobar, C ^a   Ponce, C ^a   Silveira, A C ^a   Velazquez, G ^a   Zingales, B ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIPERMETHRIN; CORTICOSTEROID; CYFLUTHRIN; CYHALOTHRIN; DELTAMETHRIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERGOSTEROL; INSECTICIDE; ITRACONAZOLE; KETOCONAZOLE; MANNITOL; MILTEFOSINE; NIFURTIMOX; POSACONAZOLE; PROTEINASE INHIBITOR; PYRETHROID; SEDATIVE AGENT; SPIRONOLACTONE; UNINDEXED DRUG;

ACUTE DISEASE; CENTRAL AMERICA; CHAGAS DISEASE; CHRONIC DISEASE; CONFERENCE PAPER; CONGENITAL INFECTION; DISEASE TRANSMISSION; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; HEALTH EDUCATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; INCIDENCE; INSECT CONTROL; LABORATORY TEST; MEGACOLON; MEGAESOPHAGUS; MEXICO; MYOCARDITIS; NONHUMAN; PROTOZOAL INFECTION; SEIZURE; SIDE EFFECT; SOUTH AMERICA; THROMBOEMBOLISM; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; WORLD HEALTH ORGANIZATION;

EID: 0036294520     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (93)

1. Chagas disease. A clinical, epidemiologic and pathologic study
2. Fase aguda
3. Forma digestiva da doeņa de Chagas
4. Chagasic cardiomyopathy
5. Involvement of the peripheral sensory nervous system in human chronic Chagas disease
6. Chagasic megavisceras
7. Enfermedad de Chagas congénita sintomática en recién nacidos y lactantes
8. Chagas disease and immunosuppression
9. Heart transplantation for chronic Chagas heart disease
10. Reactivation of chronic Chagas disease following allogenic bone marrow transplantation and successful pre-emptive therapy with benznidazole
11. Patologia da doenga de Chagas
12. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis
13. Miocardite crónica humana: Estudo quantitivo dos linfócitos CD4+ e dos CD8+ no exsudato inflamatório
14. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: Presence of tumor necrosis factor-α+ cells and dominance of granzyme A+, CD8+ lymphocytes
15. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease
16. Myocardial parasite persistence in chronic chagasic patients
17. Genetic characterization of T. cruzi directly from tissues of patients with chronic Chagas' disease. Differential distribution of genetic types into diverse organs
18. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy
19. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease
20. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrom
21. Chagas' disease and the autoimmunity hypothesis
22. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus
23. Autoimmunity in Chagas disease cardiopathy: Biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen
24. Functional implication of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia
25. Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals
26. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: Pathological implications
27. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: Comparison with myocardial rejection process
28. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8 and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes
29. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic patients in rural endemic areas
30. Treatment of congenital Chagas's disease diagnosed and followed up by the polymerase chain reaction
31. Diagnóstico laboratorial da infeçao pelo Trypanosoma cruzi
32. Multicentric double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents
33. Recombinant Trypanosoma cruzi antigens and Chagas' disease diagnosis: Analysis of a workshop
34. Evaluation of recombinant antigens for Chagas disease serodiagnosis in South and Central America
35. Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection
36. Chemotherapy of chronic Chagas' disease with benznidazole in children in the indeterminate phase of Chagas disease
37. Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-up
38. Designer drugs: Pipe-dreams or realities?
39. In vitro antiproliferative effects and mechanisms of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi
40. Chemotherapy of Chagas' disease: The how and the why
41. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies
42. Caracterização Caracterizagao de cepas do Trypanosoma cruz/isoladas cruzi isoladas do Recôncavo Baiano
43. Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification
44. Population genetics of parasitic protozoa and other microorganisms
45. Strains and clones of Trypanosoma cruzi can be characterized by restriction endonuclease fingerprinting of kinetoplast DNA minicircles
46. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi
47. Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences
48. Recommendations from a satellite meeting
49. Host specificity of ribosomal DNA variants in sylvatic Trypanosoma cruzi from North America
50. Isoenzyme patterns of cultured Trypanosoma cruzi: Changes after prolonged subculture
51. Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences
52. Different behaviour of two Trypanosoma cruzi major clones: Transmission and circulation in young Bolivian patients
53. Trypanosoma cruzi genome project: Biological characteristics and molecular typing of clone CL Brener
54. Hybridization mapping of Trypanosoma cruzi chromosomes III and IV
55. Chromosome specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation in Trypanosoma cruzi
56. The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions
57. Addenda et corrigenda
58. Geographical distribution and alti-latitudinal dispersion
59. Bioclimatic factors and zones of life
60. Comparative kinetics of bloodmeal intake by Triatoma infestans and Rhodnius prolixus, the two principal vectors of Chagas disease
61. Current status of vector transmission control of Chagas' disease in the Americas
62. Genetic variability and differentiation between populations of Rhodnius prolixus and R. pallescens, vectors of Chagas disease in Colombia
63. Morphometric differentiation evidenced between two geographic populations of Triatoma infestans in Paraguay
64. Uso de marcadores genéticos en la vigilancia entomologica de la enfermedad de Chagas
65. The use of morphometrics in entomological surveillance of sylvatic foci of Triatoma infestans in Bolivia
66. Population structure of Andean Triatoma infestans: Allozyme frequencies and their epidemiological relevance
67. Epidemiologia
68. Epidemiological role of humans, dogs and cats in the transmission of Trypanosoma cruzi in a central area of Argentina
69. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. I. The dog reservoir: An epidemiological profile
70. Estudio de la prevalencia de la infección por Trypanosoma cruzi en zarigüeyas (Didelphis albiventris) en Santiago del Estero, Argentina
71. Progress towards interruption of transmission of Chagas disease
72. Interruption of Chagas' disease transmission through vector elimination
73. Decrease in the prevalence of infection by Trypanosoma cruzi (Chagas' disease) in young men of Argentina
74. Inquérito sorológico de la prevalência de la infeçä chagasica no Brasil, 1975-1980
75. Chagas disease: Interruption of transmission in Brazil
76. Enfermedad de Chagas en Chile. Sectores rurales y periurbanos del area endemoenzootica. Relación entre las condiciones habitacionales, infestación triatominica domiciliar e infección por Trypanosoma cruzi en el vector, humanos y animales domésticos
77. Chagas disease: Interruption of transmission in Chile
78. Chagas disease and blood transfusion
79. Seroprevalencia de anticuerpos contra Trypanosoma cruzi en 13 departamentos del Uruguay
80. Chagas disease: Interruption of transmission in Uruguay
81. Evaluation of hyperactivity produced by pyrethroid treatment on third instar nymphs of Triatoma infestans
82. OMS protocolo de evaluación de efecto insecticida sobre tríatominos
83. Insecticide resistance in Brazilian Triatoma infestans and Venezuelan Rhodnius prolixus
84. Elimination of vector-borne transmission of Chagas disease
85. Seroprevalencia de la infección por Trypanosoma cruzi en escolares de 6 y 12 años de edad de tres departamentos endémicos de Uruguay
86. Evaluación de los programas de erradicación de la enfermedad de Chagas en Chile mediante estudio serológico de niños menores de 10 años
87. Chagas disease: Progress towards interruption of transmission in Venezuela
88. Elimination of the vectorial transmission of Chagas disease in Central American countries